• br c Typically initiated as

  2020-07-27

  

  c Typically initiated as neo-adjuvant treatment, however detection of liver metastases resulted in cancellation of the surgery. Table 3 Short-term survival for older pancreatic cancer patients, according to stage. OS NL (%) OS Moffitt (%) Comparison HR (95%CI)a p-value 1-year Overall

• DETA NONOate br expression Error bars represent the mean SD

  2020-07-27

  

  expression. Error bars represent the mean þ SD, n ¼ 3, *p 4. DISCUSSION Increasing evidence supports that statins possess anti-cancer prop-erties; however, in PCa, a broad range of sensitivity to fluvastatin was observed (Figure 3A). In order to advance statins as anti-cancer agents for the t

• br For dioxane chloroacetophenone and acrylamide air toxic c

  2020-07-06

  

  For 1,4-dioxane, 2-chloroacetophenone, and acrylamide, air toxic concentrations were missing for 1210 (2.4%), 369 (0.7%), and 4096 (8.2%) women, respectively, because NATA modeling was not complete for their census tract; therefore, these women with missing air toxic estimates were not included in

• br This study further provides the direct

  2020-07-04

  

  This study further provides the direct evidence that adoptively trans-ferred NKG2Dp CAR-NK Tigecycline did recognize tumor cells and display antitumor effector functions in patients with metastatic colorectal cancer. Notably, our small patient population consisted of heavily treated, refractory pa

• br CDK expression induces vemurafenib resistance in

  2020-03-24

  

  3.2. CDK1 expression induces vemurafenib resistance in colon cancer To study the functional role of CDK1 in vemurafenib resistance, two colon cancer cell lines with stable overexpression of CDK1 (Fig. 2A) Fig. 2. CDK1 induces vemurafenib resistance in colon cancer cells. (A) Successful estab

• NCT-501 br Introduction br Colon cancer is the third most

  2020-03-24

  

  1. Introduction Colon cancer is the third most common malignancy, and more than 1,800,000 new cases were estimated to have been diagnosed worldwide in 2018. Among these new cases, an increasing incidence of colon cancer are being reported in adolescents and young adults [1–3]. Given that tradit

• Iberiotoxin br Appendix A Supplementary data br References b

  2020-03-24

  

  Appendix A. Supplementary data References 1. Yersal O, Barutca S. Biological subtypes of breast cancer: prognostic and therapeutic implications. World J Clin Oncol. 2014;5:412e424. 4. Omarini C, Guaitoli G, Pipitone S, et al. Neoadjuvant treat-ments in triple-negative breast cancer patien

• br The increased e ectiveness of some

  2020-03-24

  

  The increased effectiveness of some of the NAX compounds in inhibiting proliferation could be due to multiple mechanisms. Some of the NAX compounds could induce more DNA damage than other which could result in cell death. Some of the NAX compounds Fig. 6. Effects of the Nutraceuticals Berberine A

• br Has anyone explained what

  2020-03-17

  

  Has anyone explained what you should do with the medication that Bradykinin (acetate) your relative was taking before admission 56.25 6.25 to the hospital? Has anyone explained what to do and how to alert the medical staff if your relative needs anything? 93.75 6.25 Well Barely adeq

• br Ghaffari M Fatehizade M Ahmadi

  2019-11-11

  

  Ghaffari, M., Fatehizade, M., Ahmadi, A., Ghasemi, V., & Baghban, I. (2013). Predictors of family strength: The integrated spiritual-religious/resilient perspective for under-standing the healthy/strong family. Iranian Journal of Psychiatry and Behavioral Sci-ences, 7(2), 57–67. Gibbons, F. X.

• br Four team members R S S

  2019-11-11

  

  Four team members (R.S.S., N.P.C., C.L.M., and J.O.) thematically analyzed a subset of interview transcripts (n ¼ 8) to develop an initial coding framework.27 After the open coding process, trained study team members coded all tran-scripts using NVivo software (QSR International, Victoria, Austral

• Allele NSCLC HC OR br p for all

  2019-11-11

  

  Allele NSCLC HC OR χ2, p for all Note: (1) Abbreviations: NSCLC, non-small cell lung cancer; HC, healthy controls; OR, odds ratio; CI, confidence interval; N, number of genotype or allele gene. (2) a Fisher’s exact test; * p Fig. 2. IRF5 protein levels in the WBCs of the NSCLC patients.

• br Kaplan EL Meier P Nonparametric estimation from

  2019-11-07

  

  39. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:25.  40. Team RC. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2018. 41. Team RS. RStudio: Integrated Development

• (±)-Baclofen br ACCEPTED br reported outcomes in clinic

  2019-11-06

  

  ACCEPTED reported outcomes in clinical practice: a systematic review of the literature, Qual Life Donaldson, Automated home monitoring and management of patient-reported symptoms during chemotherapy: results of the symptom care at home RCT, Cancer A.-L. Septans, M. Balavoine, S. Landry

• br For the second screening phase we divided the

  2019-10-30

  

  For the second screening phase, we divided the 53 CRC patients according to the TNM staging system into two groups, namely, 33 pa-tients with stage IeII CRC (Group 1) and 20 patients with stage III–IV CRC (Group 2). The 16 candidate miRNAs were tested in the three plasma groups from the above two

167 records 8/12 page Previous Next First page Previous 5 pages 678910 Next 5 pages Last page